PURPOSE: Population-based newborn screening using T-cell receptor excision circles (TREC) identifies infants with severe T-lymphopenia, seen in severe combined immunodeficiencies (SCID), but also infants with the 22q11 deletion syndrome (22q11DS). Methods for analysis of kappa-deleting recombination excision circles (KREC) help identifying infants with B-lymphopenia. We aimed to evaluate the occurrence of abnormal TREC or KREC newborn screening results in 22q11DS patients and assessed the clinical relevance of abnormal screening reports. METHODS: Simultaneous TREC and KREC analysis was performed on stored original Guthrie cards. Patients with abnormal screening reports were compared to patients with normal reports, regarding lymphocyte counts and clinical severity, obtained by retrospective analysis of medical charts. RESULTS: Of 48 included patients, nine (19 %) had abnormal TREC copy numbers. All 22q11DS patients with abnormal TRECs had CD3+ T-lymphopenia at the time of diagnosis, but only one patient had the complete DiGeorge syndrome. Identified 22q11DS patients with abnormal TREC copy numbers showed significantly lower CD8+ T-lymphocytes at time-of-diagnosis and were significantly more prone to viral infections, compared to 22q11DS patients with normal TREC copy numbers. All 22q11DS patients showed KREC copies within the normal range. CONCLUSIONS: In this retrospective study a high proportion of 22q11DS patients were identified by TREC-based newborn screening. Although only one of them had the complete DiGeorge syndrome with no T-lymphocytes, all of them had T-lymphopenia and most of them had recurrent viral infections, as well as other medical problems, warranting early recognition of the syndrome.
PURPOSE: Population-based newborn screening using T-cell receptor excision circles (TREC) identifies infants with severe T-lymphopenia, seen in severe combined immunodeficiencies (SCID), but also infants with the 22q11 deletion syndrome (22q11DS). Methods for analysis of kappa-deleting recombination excision circles (KREC) help identifying infants with B-lymphopenia. We aimed to evaluate the occurrence of abnormal TREC or KREC newborn screening results in 22q11DS patients and assessed the clinical relevance of abnormal screening reports. METHODS: Simultaneous TREC and KREC analysis was performed on stored original Guthrie cards. Patients with abnormal screening reports were compared to patients with normal reports, regarding lymphocyte counts and clinical severity, obtained by retrospective analysis of medical charts. RESULTS: Of 48 included patients, nine (19 %) had abnormal TREC copy numbers. All 22q11DS patients with abnormal TRECs had CD3+ T-lymphopenia at the time of diagnosis, but only one patient had the complete DiGeorge syndrome. Identified 22q11DS patients with abnormal TREC copy numbers showed significantly lower CD8+ T-lymphocytes at time-of-diagnosis and were significantly more prone to viral infections, compared to 22q11DS patients with normal TREC copy numbers. All 22q11DS patients showed KREC copies within the normal range. CONCLUSIONS: In this retrospective study a high proportion of 22q11DS patients were identified by TREC-based newborn screening. Although only one of them had the complete DiGeorge syndrome with no T-lymphocytes, all of them had T-lymphopenia and most of them had recurrent viral infections, as well as other medical problems, warranting early recognition of the syndrome.
Authors: Lucinda Brown; Jinhua Xu-Bayford; Zoe Allwood; Mary Slatter; Andrew Cant; E Graham Davies; Paul Veys; Andrew R Gennery; H Bobby Gaspar Journal: Blood Date: 2011-01-27 Impact factor: 22.113
Authors: Ruud H J Verstegen; Stephan Borte; Levinus A Bok; Paul H Th van Zwieten; Ulrika von Döbeln; Lennart Hammarström; Esther de Vries Journal: J Allergy Clin Immunol Date: 2013-12-09 Impact factor: 10.793
Authors: Kiran Patel; Javeed Akhter; Lisa Kobrynski; M A Benjamin Gathmann; Benjamin Gathman; Onika Davis; Kathleen E Sullivan Journal: J Pediatr Date: 2012-07-17 Impact factor: 4.406
Authors: Aoy Tomita-Mitchell; Donna K Mahnke; Joshua M Larson; Sujana Ghanta; Ying Feng; Pippa M Simpson; Ulrich Broeckel; Kelly Duffy; James S Tweddell; William J Grossman; John M Routes; Michael E Mitchell Journal: Physiol Genomics Date: 2010-06-15 Impact factor: 3.107
Authors: Antonia Kwan; Joseph A Church; Morton J Cowan; Rajni Agarwal; Neena Kapoor; Donald B Kohn; David B Lewis; Sean A McGhee; Theodore B Moore; E Richard Stiehm; Matthew Porteus; Constantino P Aznar; Robert Currier; Fred Lorey; Jennifer M Puck Journal: J Allergy Clin Immunol Date: 2013-07 Impact factor: 10.793
Authors: Abbas F Jawad; Eline Luning Prak; Jean Boyer; Donna M McDonald-McGinn; Elaine Zackai; Kenyetta McDonald; Kathleen E Sullivan Journal: J Clin Immunol Date: 2011-08-24 Impact factor: 8.317
Authors: Suellen Moli Yin; Ronald M Ferdman; Larry Wang; M Louise Markert; Jonathan S Tam Journal: J Clin Immunol Date: 2015-06-07 Impact factor: 8.317
Authors: Kiran A Gul; Torstein Øverland; Liv Osnes; Lars O Baumbusch; Rolf D Pettersen; Kari Lima; Tore G Abrahamsen Journal: J Clin Immunol Date: 2015-03-27 Impact factor: 8.317
Authors: Jessica C Barry; Terrence Blaine Crowley; Soma Jyonouchi; Jennifer Heimall; Elaine H Zackai; Kathleen E Sullivan; Donna M McDonald-McGinn Journal: J Clin Immunol Date: 2017-05-24 Impact factor: 8.317
Authors: Jet van der Spek; Rolf H H Groenwold; Mirjam van der Burg; Joris M van Montfrans Journal: J Clin Immunol Date: 2015-04-17 Impact factor: 8.317
Authors: Marilia Pyles P Kanegae; Lucila Akune Barreiros; Jusley Lira Sousa; Marco Antônio S Brito; Edgar Borges de Oliveira; Lara Pereira Soares; Juliana Themudo L Mazzucchelli; Débora Quiorato Fernandes; Sonia Marchezi Hadachi; Silvia Maia Holanda; Flavia Alice T M Guimarães; Maura Aparecida P V V Boacnin; Marley Aparecida L Pereira; Joaquina Maria C Bueno; Anete Sevciovic Grumach; Regina Sumiko W Di Gesu; Amélia Miyashiro N Dos Santos; Newton Bellesi; Beatriz T Costa-Carvalho; Antonio Condino-Neto Journal: Rev Paul Pediatr Date: 2017 Jan-Mar